Citation: | FEI Huizhi, HU Xiaoya, QIU Hongmei, LIU Dan, ZHOU Qixin. Improvement of NET and 5-HTT expression involved in the anti-depressive effect of valproate[J]. Journal of China Pharmaceutical University, 2016, 47(4): 474-478. DOI: 10.11665/j.issn.1000-5048.20160414 |
[1] |
World Health Organization.Fact sheets N° 369:depression[EB/OL].(2015-10-01)[2016-01-04] .http://www.who.int/mediacentre/factsheets/fs369/en/.html.
|
[2] |
Dedovic K,Duchesne A,Engert V,et al.Psychological,endocrine and neural responses to social evaluation in subclinical depression[J]. Soc Cogn Affect Neurosci,2014,9(10): 1632-1644.
|
[3] |
Quesseveur G,Gardier AM,Guiard BP.The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs[J].Curr Drug Targets,2013,14(11):1277-1294.
|
[4] |
Fornaro M,McCarthy MJ,DeBerardis D,et al.Adjunctive agomelatine therapy in the treatment of acute bipolar II depression:a preliminary open label study[J].Neuropsych Dis Treat,2013,9:243-251.
|
[5] |
Xie JP,Ren ZB,Ma YC,et al.Comparing study on therapeutic of outpatients with agitated or anxiety depression by combination of SSRI and sodium valproate RX [J].Chin J Clin Pharm Ther(中国临床药理学与治疗学),2013,18(1):86-89.
|
[6] |
Unterecker S,Reif A,Hempel S,et al.Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine:analysis of therapeutic drug monitoring data under naturalistic conditions[J].Int Clin Psychopharma,2014,29(4):206-211.
|
[7] |
Maes M,Kubera M,Obuchowiczwa E,et al.Depression′s multiple comorbidities explained by(neuro)inflammatory and oxidative & nitrosative stress pathways[J].Neuro Endocrinol Lett,2011,32(1):7-24.
|
[8] |
Hu XY,Li N,Fei HZ,et al.Anti-depressive effect of reboxetine on non-transporter inhibition in rats[J].Acta Acad Med Mil Tert(第三军医大学学报),2012,34(19):1977-1980.
|
[9] |
Fei HZ,Wang H,Hu XY,et al. Improvement of oxidative stress and HPA axis function and elevation of BDNF expression involved in anti-depressive effect of paroxetine in rat model[J].Chin J Clin Pharm Ther(中国临床药理学与治疗学),2012,17(10):1137-1142.
|
[10] |
Tang M,Lei JY,Sun X,et al.Stress-induced anhedonia correlates with lower hippocampal serotonin transporter protein expression[J].Brain Res,2013,1513:127-134.
|
[11] |
Chen P, Fan Y, Li Y, et al. Chronic social defeat up-regulates expression of norepinephrine transporter in rat brains[J].Neurochem Int,2012,60(1):9-20.
|
[12] |
Li N,Wang H,Wen W,et al.Improvement of oxidative/anti-oxidative stress balance and expression of NET and 5-HTT involve in the anti-depressive effect of reboxetine[J].Clin Pharmocal Bull(中国药理学通报),2011,27(9):593-597.
|
[13] |
Hu XY, Fei HZ, Jiang XH, et al. Improving oxidative stress response and reversing abnormal expression of hippocampus NET and 5-HTT involved in anti-depressive effect of venlafaxine[J].Clin Pharmocal Bull(中国药理学通报),2014,30(6):848-852.
|
[14] |
Wang LJ,Qiu HM,Jiang XH,et al.Down-regulation of monoamine neurotransmitter synthetase expression involved in CUS-induced depression of rats[J].Chin Pharmacol Bull(中国药理学通报),2015,31(4):527-531.
|
[15] |
Qin LJ,Liu D,Jiang XH,et al.Down-regulation of hyppocampal TH and TPH expression involved in CUMS induced depressive behaviors of rats and interfering effects of venlafaxine[J].Chin J Clin Pharm Ther(中国临床药理学与治疗学),2014,19(4):398-403.
|